Technical Risks and the Ethics Primacy Principle in the Clinical Application of Induced Pluripotent Stem Cells
Induced pluripotent stem cell (iPSC) technology has made breakthroughs in the therapeutic field. However, its clinical use continues to face key challenges, including low reprogramming efficiency, insufficient genetic and epigenetic stability, and prohibitively high anticipated treatment costs. On t...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Chinês |
| Publicat: |
Editorial Office of Medicine and Philosophy
2025-08-01
|
| Col·lecció: | Yixue yu zhexue |
| Matèries: | |
| Accés en línia: | https://yizhe.dmu.edu.cn/article/doi/10.12014/j.issn.1002-0772.2025.16.03 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|